Chronic Fatigue Syndrome and Celltex Stem Cell Therapy

What is Chronic Fatigue Syndrome?

Chronic fatigue syndrome is a complex disorder in which one may experience extreme fatigue that does not improve with rest and could worsen through activity. Although the cause is unknown, the syndrome may stem from viral infections, immune impairment, abnormal blood pressure, hormonal imbalance, or even elongated stress.

Chronic fatigue syndrome cannot be tested but is characterized by permanent fatigue, memory loss, muscular discomfort, inexplicable headaches, sore throat, enlarged lymph nodes, and active joint pain without swelling. While possible at any age, the syndrome is most common in one’s 40s and 50s. Chronic fatigue syndrome may complicate one’s daily routine and eventually cause social isolation.

How can Celltex stem cell therapy help?

Stem cell therapy for Chronic Fatigue Syndrome has not yet been demonstrated to be safe and effective in randomized double blinded placebo controlled trials. To date there are no clinical trials registered at FDA.gov that explore the use of mesenchymal stem cells for chronic fatigue syndrome. Also there does not appear to be any description of MSCs being used for chronic fatigue syndrome in pre-clinical models. There are studies that show administration of MSCs can help reduce fatigue with certain disease conditions (e.g. primary biliary cirrhosis), but it is important to consider that fatigue is subjective. Transplantation of Mesenchymal Stem Cells in humans for a variety of conditions has been generally well tolerated, although results have been variable as a function of delivery route. Also the variability in potency of cells between donors, tissue sources and culture conditions has been well documented.

Example studies where stem cells are described as an intervention and fatigue a condition: